2023 annual financial data
Palvella Therapeutics 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -11,869,000 USD and net income was 18,691,000 USD.
Operating cash flow was -13,703,000 USD.
Get free Palvella Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,869,000 USD
- Net income
- 18,691,000 USD
- Operating cash flow
- -13,703,000 USD